Key aim is to understand interactions between fibroblastic reticular cells and immune cells in the tumor microenvironment, which may influence cancer progression.
Primary outcome evaluates the changes in immune response influenced by fibroblastic reticular cells in lung cancer over a specified timeline.
This is a protocol for a controlled investigation focusing on cell signaling and the tumor microenvironment interactions.
Findings could lead to new therapeutic strategies in lung cancer treatment by targeting these interactions.